Bio-Rad Introduces EQAS Mobile, an Easy Way for Clinical Labs to Submit Proficiency Testing Results Using a Smartphone
HERCULES, CA –January 10, 2013 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, today announced the launch of its EQAS® Mobile (External Quality Assurance Service) that offers clinical laboratories the ability to use an iPhone® or Android™ smartphone to configure and submit their proficiency testing results to Bio‑Rad’s QCNet™ online portal (www.QCNet.com/eqasonline).
QCNet™ (www.QCNet.com) is the industry’s leading online portal to QC information, providing laboratories with an easy and rapid way to access their quality control data and other QC related information.
The EQAS Mobile platform targets mobile only internet users (MOIU) and features simple navigation to guide the smartphone user to a page of interest with minimal data plan utilization.
“EQAS Mobile offers clinical laboratories a fast and easy solution for submitting results to Bio-Rad,” said Nico Vandepoele, Bio-Rad Product Manager. “In addition, it integrates with our EQAS® Online solution, providing the same features and functionality including easy navigation; color coding of submitted, late, or missing results; and email notifications when results are due and reports are available.”
The Bio-Rad EQAS® program is fully accredited to ISO/IEC 17043:2010 and offers several comprehensive programs that include Clinical Chemistry for both serum and urine, Therapeutic Drug Monitoring, Immunoassay, Serum Proteins, Hemoglobin, Tumor Markers, Hematology, Blood Gas, Coagulation, Cardiac Markers, Ethanol/Ammonia and Lipids.
For more information, please call 1-800-224-6723 or visit www.bio-rad.com
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs over 7,100 people globally and had revenues exceeding $2 billion in 2011. For more information, visit www.bio-rad.com.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.
Bio-Rad Laboratories, Inc.
Nico Vandepoele, Product Manager